Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - RESEARCH & DEVELOPMENT
Research & Development GERN - Geron Corporation
125 M
LAST VALUE
20.77%
2 YEAR CAGR
56.24%
5 YEAR CAGR
18.37%
10 YEAR CAGR